FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Paricalcitol Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Mylan Pharmaceuticals Inc., a Viatris Company (New 01/29/2021)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
(Solution in Single Dose Vials) [0.002 mg / 1 ml] 01/29/2021
(Solution in Multi Dose Vials) [0.01 mg / 2 ml](NDC 67457-389-25) 01/29/2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English